HPSE and cancer: Such down regulation of heparanase expression raises two important points about the anti-cancer properties of PG545: firstly, it will complement the inhibition of the enzyme’s activity by PG545 and, secondly, it will also reduce the signalling of heparanase [12], [13], something that other enzymatic inhibitors may not accomplish.